Our Privacy Statment & Cookie Policy

All LSEG websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

February 15, 2021

Chart of the Week: Vaccination success leaves UK pondering exit strategy

by Fathom Consulting.

With the UK vaccination programme now having passed the government’s target of offering initial doses to the highest priority groups (over-seventies, clinically extremely vulnerable and frontline workers), focus is now turning towards the pace at which lockdowns are likely to be relaxed. As health officials are keen to stress, these decisions will be based on the spread of the disease as well as vaccine coverage. Reassuringly, both of these measures are currently moving in the right direction. Fathom’s central scenario remains optimistic, with a sharp recovery in output likely over the course of the year. A handful of countries have already recovered their pre-crisis levels. Based on the official data, the likes of Ireland, New Zealand and China managed to do this within one quarter of the relaxation of restrictions.

Refresh this chart in your browser | Edit the chart in Datastream

Join a growing community of asset managers and stay up to date with the latest research from Refinitiv and partners to help you inform your investment decisions. Follow our Asset Management LinkedIn showcase page.

________________________________________________________________________________________

Refinitiv Datastream

Financial time series database which allows you to identify and examine trends, generate and test ideas and develop view points on the market.

Refinitiv offers the world’s most comprehensive historical database for numerical macroeconomic and cross-asset financial data which started in the 1950s and has grown into an indispensable resource for financial professionals. Find out more.

Article Keywords , , ,

Get In Touch

Subscribe

We have updated our Privacy Statement. Before you continue, please read our new Privacy Statement and familiarize yourself with the terms.x